EMA recommends approval of 6-in-1 paediatric vaccine
Source: European Medicines Agency
Area: News
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of a new paediatric vaccine intended for the primary and booster vaccination of infants and toddlers from six weeks to 24 months of age against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and invasive diseases caused by Haemophilus influenzae type B (Hib). The new vaccine will be commercialised under the brand name Hexyon® in Western European countries and Hexacima® in Eastern European countries.
Please see the links below for further details.
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news
More News: Diphtheria | Drugs & Pharmacology | European Medicines Agency (EMA) | Haemophilus Influenzae (Hib) | Hepatitis | Hepatitis B | Hepatitis Vaccine | Influenza Vaccine | Pediatrics | Polio | Polio Vaccine | Tetanus | Tetanus Diptheria Pertussis Vaccine Tdap,Dtap,Dpt | Tetanus Vaccine | Vaccines | Whooping Cough (Pertussis) Vaccine